HEMATOLOGIC NEOPLASMS

Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC NEOPLASMS trials appear

Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 1 Completed 2

Could a lower drug dose make stem cell transplants safer for blood cancer patients?

Disease control Ongoing

This study looks at whether giving a lower dose of the drug cyclophosphamide after a stem cell transplant can help control blood cancers like leukemia and lymphoma with fewer side effects. About 105 people aged 15 to 65 with high-risk blood cancers will receive a transplant from …

Matched conditions: HEMATOLOGIC NEOPLASMS

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 29, 2026 15:03 UTC

HEMATOLOGIC NEOPLASMS

Get alerted when new HEMATOLOGIC NEOPLASMS trials appear

Could a lower drug dose make stem cell transplants safer for blood cancer patients?